Endoscopic Eradication Therapy for Patients With Barrett’s Esophagus–associated Dysplasia and Intramucosal Cancer

Gastrointestinal Endoscopy - United States
doi 10.1016/j.gie.2017.10.011
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Cost–effectiveness Analysis of Endoscopic Eradication Therapy for Treatment of High-Grade Dysplasia in Barrett’s Esophagus

Journal of Comparative Effectiveness Research
Health Policy
2017English

Adherence to Therapy for Barrett’s Esophagus-Associated Neoplasia

United European Gastroenterology Journal
OncologyGastroenterology
2015English

Endoscopic Ablation Is a Cost-Effective Cancer Preventative Therapy in Patients With Barrett’s Esophagus Who Have Elevated Genomic Instability

Endoscopy International Open
2016English

High-Grade Dysplasia and Intramucosal Adenocarcinoma in Barrettʼs Esophagus

Current Opinion in Gastroenterology
Gastroenterology
2012English

Long-Term Survival Following Endoscopic and Surgical Treatment of High-Grade Dysplasia in Barrett’s Esophagus

Gastroenterology
HepatologyGastroenterology
2007English

Endoscopic Mucosal Resection of Barrett's Oesophagus Containing Dysplasia or Intramucosal Cancer

Postgraduate Medical Journal
Medicine
2007English

Treatment of Barrett's Esophagus With High-Grade Dysplasia or Cancer: Predictors of Surgical Versus Endoscopic Therapy

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2008English

Increased Prevalence of Barrett’s Esophagus in Patients With MUTYH-associated Polyposis (MAP)

Familial Cancer
Cancer ResearchOncologyGenetics
2020English

Barrett’s Esophagus – Who, How, How Often and What to Do With Dysplasia?

Canadian Journal of Gastroenterology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy